Valuation: Orthofix International NV

Market Cap 48Cr 41Cr 39Cr 36Cr 67Cr 4.55TCr 68Cr 456.34Cr 178.73Cr 2.27TCr 179.16Cr 175.19Cr 7.48TCr P/E 2026 *
-10x
P/E 2027 * -13.3x
Enterprise Value 48Cr 41Cr 39Cr 36Cr 67Cr 4.55TCr 68Cr 456.34Cr 178.73Cr 2.27TCr 179.16Cr 175.19Cr 7.48TCr EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.54x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 08/01/2024
Director of Finance/CFO 55 15/01/2024
Compliance Officer - 01/02/2015
Director TitleAgeSince
Director/Board Member 66 16/03/2016
Director/Board Member 54 08/06/2020
Director/Board Member 64 05/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 48Cr
+0.87%+2.26%-17.76%-0.64% 18TCr
+0.95%+2.40%-3.79%+2.07% 11TCr
-0.32%+0.25%+6.23%+63.01% 6.06TCr
+2.37%+2.85%+44.34%+56.22% 5.18TCr
+1.80%+6.02%-5.82%-37.30% 4.56TCr
+3.64%+2.77% - - 3.32TCr
+3.57%+18.03%+13.57%-29.06% 3.15TCr
+1.78%+4.95%+45.83%-5.97% 2.4TCr
+1.17%+6.10%+1.44%+2.76% 2.23TCr
Average +1.80%+4.52%+10.50%+6.39% 6.24TCr
Weighted average by Cap. +1.45%+3.37%+0.58%+7.84%

Financials

2026 *2027 *
Net sales 84Cr 73Cr 68Cr 63Cr 118.44Cr 8.04TCr 120.51Cr 806.84Cr 316Cr 4.01TCr 316.76Cr 309.75Cr 13TCr 89Cr 77Cr 72Cr 66Cr 124.4Cr 8.44TCr 126.57Cr 847.39Cr 331.88Cr 4.21TCr 332.69Cr 325.32Cr 14TCr
Net income -4.63Cr -4.03Cr -3.76Cr -3.45Cr -6.51Cr -441.5Cr -6.62Cr -44Cr -17Cr -220.17Cr -17Cr -17Cr -726.2Cr -3.69Cr -3.2Cr -2.99Cr -2.74Cr -5.18Cr -351.25Cr -5.27Cr -35Cr -14Cr -175.16Cr -14Cr -14Cr -577.74Cr
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-